logo

For the Inventor, By the Inventor

Modiin, Israel

Itschak Lamensdorf

USPTO Granted Patents = 12 

 

Average Co-Inventor Count = 2.7

ph-index = 4

Forward Citations = 69(Granted Patents)


Company Filing History:

goldMedal4 out of 22 
 
Brainsgate Ltd.
 patents
silverMedal4 out of 4 
 
Trinutra Ltd.
 patents
bronzeMedal3 out of 4 
 
Pharmatwob Ltd.
 patents
4. 1 out of 1 
 
4p-pharma
 patent

Years Active: 2011-2022

Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 11426365 - Compositions comprising thymoquinone and omega-3 fatty acids (2022-08-30),
2. 11266701 - Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine (2022-03-08),
3. 11103458 - Stimulant abuse-deterrent compositions (2021-08-31),
4. 10675269 - Compositions comprising melatonin (2020-06-09),
5. 10159702 - Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine (2018-12-25),
6. 9943489 - Extended release formulations of rasagiline and uses thereof (2018-04-17),
7. 9259418 - Pharmaceutical compositions for treatment of Parkinson's disease (2016-02-16),
8. 9233245 - SPG stimulation (2016-01-12),
9. 8969417 - Pharmaceutical compositions for treatment of Parkinsons disease (2015-03-03),
10. 8958881 - Neuroprotective electrical stimulation (2015-02-17),
11. 8406869 - Post-acute electrical stimulation treatment of adverse cerebrovascular events (2013-03-26),
12. 8055347 - Stimulation for treating brain events and other conditions (2011-11-08),

Title: The Innovative Contributions of Itschak Lamensdorf

Introduction

Itschak Lamensdorf is a notable inventor based in Modiin, Israel, recognized for his significant contributions to the field of therapeutic compositions. With a total of 12 patents to his name, Lamensdorf has made strides in developing innovative solutions aimed at treating various health conditions.

Latest Patents

Among his latest patents, Lamensdorf has developed a composition comprising thymoquinone and omega-3 fatty acids. This invention provides a synergistic combination of these compounds, with a molar ratio of at least 1:7, aimed at treating or preventing inflammatory conditions. Another significant patent involves synergistic combinations of caffeine, ginkgo biloba, and beta-phenylethylamine. This therapeutic composition is designed for oral dosage forms and addresses psychological, psychiatric, behavioral, and neurodevelopmental disorders.

Career Highlights

Throughout his career, Lamensdorf has worked with various companies, including Brainsgate Ltd. and Trinutra Ltd. His work in these organizations has contributed to the advancement of innovative health solutions.

Collaborations

Lamensdorf has collaborated with notable individuals in his field, including Yoram Sela and Avinoam Dayan. These partnerships have further enhanced his research and development efforts.

Conclusion

Itschak Lamensdorf's innovative work and numerous patents reflect his commitment to advancing therapeutic solutions. His contributions continue to impact the field positively, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…